✦ LIBER ✦

Galantamine for Parkinson's disease with dementia

✍ Scribed by D. Aarsland

Book ID: 119576376
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 247 KB
Volume: 12
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(02)80620-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of galantamine (remi

Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)

✍ I. V. Litvinenko; M. M. Odinak; V. I. Mogil’naya; A. Yu. Emelin 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 139 KB

Cognitive, psychiatric and motor respons

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

✍ D. Aarsland; M. Hutchinson; J. P. Larsen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

## Abstract ## Background Cholinesterase inhibitors with additional nicotinic activity, such as galantamine, may be useful in PD patients with dementia (PDD) since stimulation of nicotinic receptors may prevent the down‐regualation that is likely to accompany cholinesterase inhibition and facilita

Dementia associated with Parkinson's dis

Dementia associated with Parkinson's disease

✍ Murat Emre 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 194 KB

Rivastigmine for Dementia Associated wit

Rivastigmine for Dementia Associated with Parkinson's Disease

✍ Emre, Murat; Aarsland, Dag; Albanese, Alberto; Byrne, E. Jane; Deuschl, Günther; 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 127 KB

Rivastigmine for dementia associated wit

Rivastigmine for dementia associated with Parkinson’s disease

✍ John Morgan; Kapil D. Sethi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 180 KB

Parkinson’s Disease Dementia

✍ Mary J. Docherty; David J. Burn 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 145 KB